151 related articles for article (PubMed ID: 12711449)
21. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.
Kloek J; Akkermans W; Beijersbergen van Henegouwen GM
Photochem Photobiol; 1998 Jan; 67(1):150-4. PubMed ID: 9477773
[TBL] [Abstract][Full Text] [Related]
22. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
23. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
24. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
25. On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin.
Uehlinger P; Ballini JP; van den Bergh H; Wagnières G
Photochem Photobiol; 2006; 82(4):1069-76. PubMed ID: 17205631
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy of cutaneous T-cell lymphoma cell lines mediated by 5-aminolevulinic acid and derivatives.
Vallecorsa P; Di Venosa G; Gola G; Sáenz D; Mamone L; MacRobert AJ; Ramírez J; Casas A
J Photochem Photobiol B; 2021 Aug; 221():112244. PubMed ID: 34174487
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
[TBL] [Abstract][Full Text] [Related]
29. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin.
van den Akker JT; Boot K; Vernon DI; Brown SB; Groenendijk L; van Rhoon GC; Sterenborg HJ
Photochem Photobiol Sci; 2004 Mar; 3(3):263-7. PubMed ID: 14993942
[TBL] [Abstract][Full Text] [Related]
30. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters.
Moan J; Ma LW; Iani V
Int J Cancer; 2001 Apr; 92(1):139-43. PubMed ID: 11279617
[TBL] [Abstract][Full Text] [Related]
31. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
32. In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch.
Gilmore BF; McCarron PA; Morrow DI; Murphy DJ; Woolfson AD; Donnelly RF
Eur J Pharm Biopharm; 2006 Jul; 63(3):295-309. PubMed ID: 16682177
[TBL] [Abstract][Full Text] [Related]
33. 5-Aminolevulinic acid coated microneedles for photodynamic therapy of skin tumors.
Jain AK; Lee CH; Gill HS
J Control Release; 2016 Oct; 239():72-81. PubMed ID: 27543445
[TBL] [Abstract][Full Text] [Related]
34. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
35. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
Juzeniene A; Juzenas P; Ma LW; Iani V; Moan J
Br J Dermatol; 2006 Oct; 155(4):791-9. PubMed ID: 16965430
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.
Ren QG; Wu SM; Peng Q; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):650-4. PubMed ID: 12198571
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers.
Wakui M; Yokoyama Y; Wang H; Shigeto T; Futagami M; Mizunuma H
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1143-50. PubMed ID: 20069433
[TBL] [Abstract][Full Text] [Related]
38. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo expression of protoporphyrin IX induced by lipophilic 5-aminolevulinic acid derivatives.
Ninomiya Y; Itoh Y; Tajima S; Ishibashi A
J Dermatol Sci; 2001 Oct; 27(2):114-20. PubMed ID: 11532375
[TBL] [Abstract][Full Text] [Related]
40. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum.
Winkler A; Müller-Goymann CC
Eur J Pharm Biopharm; 2005 Aug; 60(3):427-37. PubMed ID: 15996584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
